Fig. 2

Inhibition of miR-1179 enhances the Vincristine sensitivity of the human SCC-9 and SCC-25 oral cancer cells. Individual experiments were performed in triplicate and expressed as mean ± SD (*P < 0.05)
Inhibition of miR-1179 enhances the Vincristine sensitivity of the human SCC-9 and SCC-25 oral cancer cells. Individual experiments were performed in triplicate and expressed as mean ± SD (*P < 0.05)